ACLY and autoimmune polyendocrinopathy: These variables should be investigated by including them in future prospective studies; 4) The 2023 ACR/EULAR APS classification criteria emphasize the importance of distinguishing between the IgG and IgM isotypes of aCL and anti-β2GPI antibodies (4).